-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ShQXV3CLCWokYe2VYOADPTxhtsFZKZodtL6FGtZ43zXYIE7VnQ//ZGFWVAiIqPKV g891A8l+zJFxcteNRSO0pg== 0000950135-05-003948.txt : 20050715 0000950135-05-003948.hdr.sgml : 20050715 20050715165250 ACCESSION NUMBER: 0000950135-05-003948 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20050715 DATE AS OF CHANGE: 20050715 EFFECTIVENESS DATE: 20050715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OXIGENE INC CENTRAL INDEX KEY: 0000908259 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 133679168 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-126636 FILM NUMBER: 05957747 BUSINESS ADDRESS: STREET 1: 321 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 6176737800 S-8 1 b55882oisv8.htm OXIGENE, INC. sv8
Table of Contents

As filed with the Securities and Exchange Commission on July 15, 2005

REGISTRATION NO. 333 -

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM S-8

REGISTRATION STATEMENT
under the
SECURITIES ACT OF 1933
 

OXiGENE, INC.

(Exact Name of Registrant as Specified in Its Charter)
     
Delaware
(State or Other Jurisdiction
of Incorporation or Organization
)
  13-3679168
(I.R.S. Employer
Identification No.
)

230 Third Avenue
Waltham, MA 02451

(Address, Including Zip Code, of Principal Executive Offices)

OXiGENE, INC. 2005 STOCK PLAN
(Full Titles of the Plans)

Frederick W. Driscoll
OXiGENE, Inc.
230 Third Avenue
Waltham, MA 02451
781-547-5900

(Name, Address and Telephone Number, Including
Area Code, of Agent For Service
)

 

CALCULATION OF REGISTRATION FEE

                                         
 
                  Proposed     Proposed        
                  Maximum     Maximum        
  Title of     Amount to be     Offering Price     Aggregate     Amount of  
  Securities to be Registered     Registered(1)     Per Share (2)     Offering Price (2)     Registration Fee  
 
Common Stock, $0.01 par value
    2,500,000 shares     $ 4.43       $ 11,075,000       $1,303.53
 
 
Rights to purchase Common Stock
      (3 )       (3 )       (3 )     None  
 
 
(1)   The number of common shares, par value $0.01 per share (“Common Stock”), stated above consists of the aggregate number of shares which may be sold upon the exercise of options or issuance of stock awards which may hereafter be granted under the OXiGENE, Inc. 2005 Stock Plan (the “Stock Plan”). The maximum number of shares which may be sold upon the exercise of such options or issuance of stock awards granted under the Stock Plan are subject to adjustment in accordance with certain anti-dilution and other provisions of the Stock Plan. Accordingly, pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement covers, in addition to the number of shares stated above, an indeterminate number of shares which may be subject to grant or otherwise issuable after the operation of any such anti-dilution and other provisions.
 
(2)   This calculation is made solely for the purpose of determining the registration fee pursuant to the provisions of Rule 457(c) and (h) under the Securities Act as follows: (i) in the case of shares of Common Stock which may be purchased upon exercise of outstanding options, the fee is calculated on the basis of the price at which the options may be exercised; and (ii) in the case of shares of Common Stock for which options and stock awards have not yet been granted and the price of which is therefore unknown, the fee is calculated on the basis of the average of the high and low sale prices per share of the Common Stock on the Nasdaq National Market as of a date (July 11, 2005) within five business days prior to filing this Registration Statement.
 
(3)   No separate consideration will be received for the Rights.
 
 

 


Table of Contents

EXPLANATORY NOTE

     In accordance with the instructional Note to Part I of Form S-8 as promulgated by the Securities and Exchange Commission, the information specified by Part I of Form S-8 has been omitted from this Registration Statement on Form S-8 for offers of Common Stock pursuant to the Stock Plan.

 


TABLE OF CONTENTS

PART II
Item 3. Incorporation of Certain Documents by Reference
Item 4. Description of Securities
Item 5. Interests of Named Experts and Counsel
Item 6. Indemnification of Directors and Officers
Item 7. Exemption from Registration Claimed
Item 8. Exhibits
Item 9. Undertakings
SIGNATURES
INDEX TO EXHIBITS FILED WITH FORM S-8 REGISTRATION STATEMENT
Ex-4.4 Certificate of Amendment of Restated Certificate of Inc.
Ex-5 Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Ex-23.2 Consent of Ernst & Young LLP


Table of Contents

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3. Incorporation of Certain Documents by Reference.

     The following documents filed by the Registrant with the Commission are incorporated herein by reference:

     (a) The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 filed on March 15, 2005.

     (b) Amendment No. 1 on Form 10-K/A to the Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2004 filed on April 29, 2005.

     (c) The Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2005 filed on April 29, 2005.

     (d) Amendment No. 1 on Form 10-Q/A to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2005 filed on June 7, 2005.

     (e) The Registrant’s Current Report on Form 8-K filed on March 7, 2005.

     (f) The Registrant’s Current Report on Form 8-K filed on March 30, 2005.

     (g) The Registrant’s Current Report on Form 8-K filed on July 11, 2005.

     (h) The description of the Common Stock contained in the Registrant’s Registration Statement on Form 8-A (File No. 000-21990) filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), with the Commission on June 25, 1993, including any amendment or report filed for the purpose of updating such description.

     (i) The description of the Rights under the Stockholder Rights Agreement (which are currently transferred with the Registrant’s Common Stock) contained in the Registrant’s Registration Statement on Form 8-A12G (File No. 000-21990) filed under the Exchange Act with the Commission on March 30, 2005, including any amendment or report filed for the purpose of updating such description.

     All reports and other documents filed by the Registrant after the date hereof pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be part hereof from the date of filing of such reports and documents.

Item 4. Description of Securities.

     Not applicable.

Item 5. Interests of Named Experts and Counsel.

1


Table of Contents

     The validity of the issuance of the shares of Common Stock registered under this Registration Statement has been passed upon for the Registrant by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. and members of that firm, their families and trusts for their benefit own an aggregate of approximately 373 shares of Common Stock of the Registrant.

Item 6. Indemnification of Directors and Officers.

     Incorporated by reference from the Registrant’s Registration Statement on Form S-3, No. 333-109433 filed on October 3, 2003.

Item 7. Exemption from Registration Claimed.

     Not applicable.

Item 8. Exhibits.

  (4.1)   Form of Common Stock Certificate (Filed as Exhibit to the Registrant’s Registration Statement on Form S-1, as amended, No. 033-64968, and incorporated herein by reference).
 
  (4.2)   Restated Certificate of Incorporation of the Registrant (Filed as Exhibit to the Registrant’s Registration Statement on Form S-1, as amended, No. 033-64968, and incorporated herein by reference).
 
  (4.3)   Certificate of Amendment of Restated Certificate of Incorporation of the Registrant (Filed as Exhibit to the Registrant’s Annual Report of Form 10-K for the fiscal year ended December 31, 1996, No. 000-21990, and incorporated herein by reference).
 
  (4.4)   Certificate of Amendment of Restated Certificate of Incorporation of the Registrant.
 
  (4.5)   Amended and Restated By-Laws of the Registrant (Filed as Exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2004, No. 000-21990, and incorporated herein by reference).
 
  (4.6)   Stockholder Rights Agreement (Filed as Exhibit to the Registrant’s Registration Statement on Form 8-A12G, File No. 000-21990, and incorporated herein by reference).
 
  (5)   Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. as to the legality of shares being registered.
 
  (23.1)   Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in opinion of counsel filed as Exhibit 5).
 
  (23.2)   Consent of Ernst & Young LLP.
 
  (24)   Power of Attorney to file future amendments (set forth on the signature page of this Registration Statement).
 
  (99.1)   OXiGENE, Inc. 2005 Stock Plan (Filed as Exhibit to the Registrant’s Current Report on Form 8-K, File No. 000-21990, and incorporated herein by reference).

2


Table of Contents

Item 9. Undertakings.

(a)   The undersigned Registrant hereby undertakes:

(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

     (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933;

     (ii) To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represents a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement.

     (iii) To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;

     Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the Registration Statement is on Form S-3, Form S-8 or Form F-3, and the information required to be included in a post-effective amendment by those paragraphs is contained in periodic reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in this Registration Statement.

(2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

(b)   The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
 
(c)   Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange

3


Table of Contents

    Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

4


Table of Contents

SIGNATURES

     The Registrant. Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Waltham, Massachusetts on July 15, 2005.

             
    OXiGENE, Inc.    
 
           
 
  By   /s/ Frederick W. Driscoll    
 
           
 
      Frederick W. Driscoll    
 
      President and Chief Executive Officer    

     Each person whose signature appears below constitutes and appoints Frederick W. Driscoll and James B. Murphy, and each of them singly, his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them singly, for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8 of OXiGENE, Inc., and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to the attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in or about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that the attorneys-in-fact and agents or any of each of them or their substitute may lawfully do or cause to be done by virtue hereof.

     Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

         
Signature   Title   Date
/s/ Joel-Tomas Citron
  Chairman of the Board and Director   July 15, 2005
Joel-Tomas Citron
       
 
       
/s/ Frederick W. Driscoll
  President, Chief Executive Officer and Director   July 15, 2005
Frederick W. Driscoll
  (Principal executive officer)    
 
       
/s/ James B. Murphy
  Chief Financial Officer   July 15, 2005
James B. Murphy
  (Principal financial officer and principal accounting officer)    
 
       
/s/ Arthur B. Laffer
  Director   July 15, 2005
Arthur B. Laffer
       
 
       
/s/ William N. Shiebler
  Director   July 15, 2005
William N. Shiebler
       

5


Table of Contents

         
Signature   Title   Date
/s/ Per-Olof Söderberg
  Director   July 15, 2005
Per-Olof Söderberg
       
 
       
/s/ J. Richard Zecher
  Director   July 15, 2005
J. Richard Zecher
       

6


Table of Contents

OXiGENE, Inc.

INDEX TO EXHIBITS FILED WITH
FORM S-8 REGISTRATION STATEMENT

     
Exhibit    
Number   Description
(4.1)
  Form of Common Stock Certificate (Filed as Exhibit to the Registrant’s Registration Statement on Form S-1, as amended, No. 033-64968, and incorporated herein by reference).
 
   
(4.2)
  Restated Certificate of Incorporation of the Registrant (Filed as Exhibit to the Registrant’s Registration Statement on Form S-1, as amended, No. 033-64968, and incorporated herein by reference).
 
   
(4.3)
  Certificate of Amendment of Restated Certificate of Incorporation of the Registrant (Filed as Exhibit to the Registrant’s Annual Report of Form 10-K for the fiscal year ended December 31, 1996, No. 000-21990, and incorporated herein by reference).
 
   
(4.4)
  Certificate of Amendment of Restated Certificate of Incorporation of the Registrant.
 
   
(4.5)
  Amended and Restated By-Laws of the Registrant (Filed as Exhibit to the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2004, No. 000-21990, and incorporated herein by reference).
 
   
(4.6)
  Stockholder Rights Agreement (Filed as Exhibit to the Registrant’s Registration Statement on Form 8-A12G, File No. 000-21990, and incorporated herein by reference).
 
   
(5)
  Opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. as to the legality of shares being registered.
 
   
(23.1)
  Consent of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. (included in opinion of counsel filed as Exhibit 5).
 
   
(23.2)
  Consent of Ernst & Young LLP.
 
   
(24)
  Power of Attorney to file future amendments (set forth on the signature page of this Registration Statement).
 
   
(99.1)
  OXiGENE, Inc. 2005 Stock Plan (Filed as Exhibit to the Registrant’s Current Report on Form 8-K, File No. 000-21990, and incorporated herein by reference).

7

EX-4.4 2 b55882oiexv4w4.txt EX-4.4 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INC. EXHIBIT 4.4 CERTIFICATE OF AMENDMENT OF RESTATED CERTIFICATE OF INCORPORATION OF OXIGENE, INC. It is hereby certified that: FIRST: The name of the corporation is OXiGENE, Inc. (the "Corporation"). SECOND: The Restated Certificate of Incorporation of the Corporation, as amended to date, is hereby further amended by striking out Article Fourth in its entirety and by substituting in lieu of the following: "FOURTH: The aggregate number of shares of all classes of stock which the Corporation is authorized to issue is One Hundred Million (100,000,000) shares, designated Common Stock, of the par value of One Cent ($0.01) per share." THIRD: The amendment of the Restated Certificate of Incorporation herein certified has been duly adopted in accordance with the provisions of Section 228 and Section 242 of the General Corporation Law of the State of Delaware. EXECUTED, effective as of this 14th day of July 2005. OXiGENE, Inc. By: /s/ James B. Murphy -------------------------- James B. Murphy Chief Financial Officer EX-5 3 b55882oiexv5.txt EX-5 OPINION OF MINTZ, LEVIN, COHN, FERRIS, GLOVSKY AND POPEO, P.C. EXHIBIT 5 Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. One Financial Center Boston, Massachusetts 02111 617 542 6000 617 542 2241 fax July 15, 2005 OXiGENE, Inc. 230 Third Avenue Waltham, MA 02451 Gentlemen: We have acted as counsel to OXiGENE, Inc., a Delaware corporation (the "Company"), in connection with the preparation and filing with the Securities and Exchange Commission of a Registration Statement on Form S-8 (the "Registration Statement"), pursuant to which the Company is registering the issuance under the Securities Act of 1933, as amended, of a total of 2,500,000 shares (the "Shares") of its common stock, $0.01 par value per share (the "Common Stock"). This opinion is being rendered in connection with the filing of the Registration Statement. All capitalized terms used herein and not otherwise defined shall have the respective meanings given to them in the Registration Statement. In connection with this opinion, we have examined the Company's Restated Certificate of Incorporation, as amended, and Amended and Restated By-Laws, both as currently in effect; such other records of the corporate proceedings of the Company and certificates of the Company's officers as we have deemed relevant; and the Registration Statement and the exhibits thereto. In our examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified or photostatic copies and the authenticity of the originals of such copies. Based upon the foregoing, we are of the opinion that (i) the Shares have been duly and validly authorized by the Company and (ii) the Shares, when sold, will have been duly and validly issued, fully paid and non-assessable shares of the Common Stock, free of preemptive rights. Our opinion is limited to the applicable provisions of the Delaware Constitution, the General Corporation Laws of the State of Delaware and the reported judicial decisions interpreting those laws, and we express no opinion with respect to the laws of any other jurisdiction. No opinion is expressed herein with respect to the qualification of the Shares under the securities or blue sky laws of any state or any foreign jurisdiction. We understand that you wish to file this opinion as an exhibit to the Registration Statement, and we hereby consent thereto. Very truly yours, /s/ Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. EX-23.2 4 b55882oiexv23w2.txt EX-23.2 CONSENT OF ERNST & YOUNG LLP EXHIBIT 23.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the OXiGENE, Inc. 2005 Stock Plan of our reports dated March 9, 2005, with respect to the consolidated financial statements of OXiGENE, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2004, OXiGENE, Inc. management's assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of OXiGENE, Inc., filed with the Securities and Exchange Commission. /s/ Ernst & Young LLP Boston, Massachusetts July 14, 2005
-----END PRIVACY-ENHANCED MESSAGE-----